Literature DB >> 23159120

Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw.

Frank Wilde1, Marcus Heufelder, Kai Lorenz, Susanne Liese, Jan Liese, Jens Helmrich, Alexander Schramm, Alexander Hemprich, Edgar Hirsch, Karsten Winter.   

Abstract

OBJECTIVES: Investigations of cone beam computed tomography (CBCT) for bisphosphonate-related osteonecrosis of the jaw (BRONJ) imaging are rare. The purpose of this study was to investigate the prevalence of typical radiological findings of BRONJ in CBCT.
METHODS: Twenty-seven CBCTs of BRONJ sites were assessed on the basis of the radiological findings (cancellous bone destruction, cortical bone erosion, sequestration, osteosclerosis, and periostal bone formation) and put in relation to the severity of the BRONJ sites.
RESULTS: Cancellous bone destruction and cortical bone erosion were the most common findings. Occurrence seems to decrease with decreasing BRONJ severity. Sequestration and osteosclerosis were less frequent and could be seen across all stages. Periosteal bone formation occurred in high-stage BRONJ only.
CONCLUSION: Cancellous bone destruction, cortical bone erosion, sequestration, and osteosclerosis can be seen across all stages and prevalence seems to decrease with decreasing severity of BRONJ. The occurrence of periosteal new bone formation seems to start in high-stage BRONJ.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159120     DOI: 10.1016/j.oooo.2012.08.458

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  22 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

2.  Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Authors:  N Ersan; L J van Ruijven; A L J J Bronckers; V Olgaç; D Ilgüy; V Everts
Journal:  Dentomaxillofac Radiol       Date:  2013-10-29       Impact factor: 2.419

3.  Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis.

Authors:  Kamile Leonardi Dutra; Letícia Fernanda Haas; Glaucia S Zimmermann; Gilberto Melo; Mariana Comparotto Minamisako; Carlos Flores-Mir; Márcio Corrêa
Journal:  Dentomaxillofac Radiol       Date:  2018-11-07       Impact factor: 2.419

4.  Cone beam computed tomography for diagnosis of bisphosphonate-related osteonecrosis of the jaw: evaluation of quantitative and qualitative image parameters.

Authors:  Roman Guggenberger; Emrah Koral; Wolfgang Zemann; Christine Jacobsen; Gustav Andreisek; Philipp Metzler
Journal:  Skeletal Radiol       Date:  2014-07-05       Impact factor: 2.199

5.  Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws.

Authors:  Akrivoula Soundia; Danny Hadaya; Sanjay M Mallya; Tara L Aghaloo; Sotirios Tetradis
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-08-29

6.  Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?

Authors:  Christoph Klingelhöffer; Manja Klingelhöffer; Steffen Müller; Tobias Ettl; Ulrich Wahlmann
Journal:  Dentomaxillofac Radiol       Date:  2016-05-23       Impact factor: 2.419

7.  CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.

Authors:  Akira Baba; Tazuko K Goto; Hiroya Ojiri; Mutsumi Takagiwa; Chiho Hiraga; Masahiro Okamura; Sho Hasegawa; Yumi Okuyama; Nobuhiro Ogino; Hideomi Yamauchi; Yuko Kobashi; Shinji Yamazoe; Yohei Munetomo; Takuji Mogami; Takeshi Nomura
Journal:  Dentomaxillofac Radiol       Date:  2018-02-13       Impact factor: 2.419

8.  Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Authors:  Hiroaki Shimamoto; Tristan R Grogan; Tomomi Tsujimoto; Naoya Kakimoto; Shumei Murakami; David Elashoff; Tara L Aghaloo; Sotirios Tetradis
Journal:  Dentomaxillofac Radiol       Date:  2017-12-15       Impact factor: 2.419

9.  Osseous changes in patients with medication-related osteonecrosis of the jaws.

Authors:  Zeynep Burcin Gönen; Canay Yillmaz Asan; Gökmen Zararsiz; Erdem Kiliç; Alper Alkan
Journal:  Dentomaxillofac Radiol       Date:  2017-11-01       Impact factor: 2.419

10.  Are there any differences in mandibular morphology of patients with bisphosphonate-related osteonecrosis of jaws?: a case-control study.

Authors:  Gozde Ozcan; Ahmet E Sekerci; Zeynep B Gönen
Journal:  Dentomaxillofac Radiol       Date:  2016-05-16       Impact factor: 2.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.